Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diarrhea × telotristat ethyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Serotonin Syndrome 3 Neuroendocrine Tumors 3 Pancreatic Neoplasms 1 Diarrhea 1 Carcinoid Tumor 1 Biliary Tract Neoplasms 1

Interventions

Octreotide 2 telotristat ethyl 1 isatuximab 1 ceterizine hydrochloride 1 capivasertib 1 cabazitaxel 1 XRP6258 1 Prednisone 1 Loperamide 1 Leucovorin 1 Lapatinib 1 Irinotecan 1 Injections 1 Granulocyte Colony-Stimulating Factor 1 Fulvestrant 1 Fluorouracil 1 Filgrastim 1 Drugs, Investigational 1 Cyclophosphamide 1 Colesevelam Hydrochloride 1 Cell- and Tissue-Based Therapy 1 Capecitabine 1 Calcium Aluminosilicate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04713202 2023-02-10

NET-PACS

Big Ten Cancer Research Consortium

Phase 2 Withdrawn

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡